These data suggest that TrxR induction might be an adaptive response to mTOR inhibitors, and TrxR inhibition is an effective pharmacologic approach for increasing therapeutic efficacy of mTOR inhibitors to cancer cells. This evidence concerns the gene MTOR and cancer.